A detailed history of Great Valley Advisor Group, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 31,450 shares of ZTS stock, worth $5.11 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
31,450
Previous 30,436 3.33%
Holding current value
$5.11 Million
Previous $5.28 Million 16.45%
% of portfolio
0.16%
Previous 0.15%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$172.58 - $196.48 $174,996 - $199,230
1,014 Added 3.33%
31,450 $6.14 Million
Q2 2024

Jul 16, 2024

BUY
$145.54 - $178.83 $734,977 - $903,091
5,050 Added 19.89%
30,436 $5.28 Million
Q1 2024

May 03, 2024

BUY
$165.67 - $199.94 $272,858 - $329,301
1,647 Added 6.94%
25,386 $4.3 Million
Q4 2023

Feb 05, 2024

SELL
$151.44 - $200.09 $25,139 - $33,214
-166 Reduced 0.69%
23,739 $4.69 Million
Q3 2023

Nov 06, 2023

BUY
$167.14 - $192.77 $229,316 - $264,480
1,372 Added 6.09%
23,905 $4.16 Million
Q2 2023

Aug 10, 2023

BUY
$160.94 - $186.23 $343,285 - $397,228
2,133 Added 10.46%
22,533 $3.88 Million
Q1 2023

May 02, 2023

BUY
$145.48 - $175.02 $430,038 - $517,359
2,956 Added 16.95%
20,400 $3.4 Million
Q4 2022

Jan 31, 2023

BUY
$131.14 - $157.47 $192,644 - $231,323
1,469 Added 9.2%
17,444 $2.56 Million
Q3 2022

Oct 21, 2022

BUY
$148.29 - $182.55 $342,253 - $421,325
2,308 Added 16.89%
15,975 $2.37 Million
Q2 2022

Jul 19, 2022

BUY
$155.97 - $200.09 $116,509 - $149,467
747 Added 5.78%
13,667 $2.35 Million
Q1 2022

Apr 20, 2022

BUY
$181.39 - $234.03 $146,563 - $189,096
808 Added 6.67%
12,920 $2.52 Million
Q4 2021

Feb 10, 2022

BUY
$193.69 - $247.03 $71,665 - $91,401
370 Added 3.15%
12,112 $2.9 Million
Q3 2021

Oct 14, 2021

BUY
$189.29 - $209.69 $88,966 - $98,554
470 Added 4.17%
11,742 $2.28 Million
Q2 2021

Jul 27, 2021

BUY
$155.9 - $187.99 $1.39 Million - $1.67 Million
8,907 Added 376.62%
11,272 $2.05 Million
Q1 2021

Apr 20, 2021

SELL
$144.0 - $169.39 $114,912 - $135,173
-798 Reduced 25.23%
2,365 $372,000
Q4 2020

Jan 29, 2021

SELL
$157.07 - $174.35 $24,188 - $26,849
-154 Reduced 4.64%
3,163 $524,000
Q3 2020

Oct 21, 2020

SELL
$137.1 - $165.37 $68,138 - $82,188
-497 Reduced 13.03%
3,317 $548,000
Q2 2020

Jul 31, 2020

BUY
$111.92 - $142.53 $210,185 - $267,671
1,878 Added 97.0%
3,814 $523,000
Q1 2020

May 15, 2020

BUY
$92.66 - $144.94 $2,038 - $3,188
22 Added 1.15%
1,936 $228,000
Q4 2019

Feb 10, 2020

BUY
$116.25 - $133.25 $222,502 - $255,040
1,914 New
1,914 $253,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $76.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Great Valley Advisor Group, Inc. Portfolio

Follow Great Valley Advisor Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.